U.S.based patient advocacy organizations received majority of pharma donations finds study

U.S.-based patient advocacy organizations received majority of pharma donations, finds study

A new study by Johns Hopkins Bloomberg School of Public Health researchers found that U.S.-based patient advocacy organizations received a disproportionate amount of contributions made by the world's 10 largest pharmaceutical companies in 2016.

More From BioPortfolio on "U.S.-based patient advocacy organizations received majority of pharma donations, finds study"